| Literature DB >> 28785734 |
Hwangbo Yong1, Hae-In Oh1, Sang-Hee Lee2, Hee-Tae Cheong3, Boo-Keun Yang1, Choon-Keun Park1.
Abstract
This study was conducted to investigate stimulatory effect of epidermal growth factor (EGF) on nuclear maturation and the expression level of EGF-receptor (EGFR), GM-130 (a marker of Golgi apparatus), transport protein Sec61 subunit beta (Sec61β), and coatomer protein complex subunit gamma 2 (COPG2) in porcine oocytes. The cumulus-oocyte complexes were collected from follicle with 3-6 mm in diameter. They were incubated in medium with/without EGF for 22 h (IVMⅠ) and subsequently incubated hormone-free medium with/without EGF for 22 h (IVMⅡ). Nuclear maturation state was checked by aceto-orcein stain. Protein expression of EGFR, GM-130, Sec61β, and COPG2 were measured by immunofluorescence. In results, nuclear maturation of oocytes in EGF non-treated oocytes were significantly lower than EGF-treated groups at IVMⅠ or IVMⅡ stage (P<0.05), whereas maturational rate in EGF treatment groups at both of IVM stage was higher in among the all treatment groups (P<0.05). EGFR, GM-130, Sec61β and COPG2 were expressed in the cytoplasm of oocytes. Especially, GM-130 and EGFR were strongly expressed, but Sec61β and COPG2 were weakly expressed in cortical area of cytoplasm. The protein level of GM-130, Sec61β, and COPG2 were significantly higher in the EGF-treated groups (P<0.05). However EGFR was no difference between non EGF-treated groups and control. In conclusion, EGF plays an important role in the systems for oocyte maturation with endoplasmic reticulum and Golgi apparatus. In addition, the protein levels of Sec61β and COPG2 could be changed by EGF in the porcine oocytes during maturation.Entities:
Keywords: Epidermal growth factor; In vitro maturation; Porcine oocyte; Transport protein
Year: 2017 PMID: 28785734 PMCID: PMC5532305 DOI: 10.12717/DR.2017.21.2.131
Source DB: PubMed Journal: Dev Reprod ISSN: 2465-9525
Effect of epidermal growth factor on nuclear maturation of porcine oocytes during different in vitro maturation condition
| EGF treatment(*IVMⅠ/**IVMⅡ) | No. of oocytes | No. of (%) | |
|---|---|---|---|
| aImmature oocyte | bMature oocyte | ||
| + / + | 130 | 52 (40.0 ± 2.2)c | 78 (60.0 ± 2.2)e |
| + / – | 148 | 100 (67.6 ± 0.4)d | 48 (32.4 ± 0.4)d |
| – / + | 137 | 100 (73.0 ± 7.4)d | 37 (27.0 ± 7.4)d |
| – / – | 136 | 118 (86.8 ± 7.3)e | 18 (13.2 ± 7.3)c |
The data are present as mean ± SEM from 3 replicates.
a Immature oocytes include germinal vesicle, germinal vesicle breakdown, metaphase, and telophaseⅠphase oocytes.
b Mature oocytes include only metaphaseⅡ oocytes.
c-e Different superscript in the same column indicate significant difference (P<0.05).
* A period that is first 22 hour at in vitro maturation (IVM).
** Subsequent maturation stage for 22 hour after IVMⅠ.
Fig. 1Effect of epidermal growth factor (EGF) on expression of EGF receptor (EGFR) in porcine oocyte during in vitro maturation.
(A) Immunofluorescence image of EGFR in maturate porcine oocyte with/without EGF (scale bar: 50 µm), (B) com-parison of fluorescence intensity.
Fig. 2Effect of epidermal growth factor (EGF) on expression of GM-130 in porcine oocyte during in vitro maturation.
(A) Immunofluorescence image of GM-130 in maturate porcine oocyte with/ without EGF (scale bar: 50 µm), (B) comparison of fluorescence intensity. Asterisk indicate significant difference (P<0.05).
Fig. 3Effect of epidermal growth factor (EGF) on expression of Sec61 subunit beta (Sec61β) in porcine oocyte during in vitro maturation.
(A) Immunofluorescence image of Sec61β in maturate porcine oocyte with/without EGF (scale bar: 50 µm), (B) comparison of fluorescence intensity. Asterisk indicate significant difference (P<0.05).
Fig. 4Effect of epidermal growth factor (EGF) on expression of coatomer protein complex subunit gamma 2 (COPG2) in porcine oocyte during in vitro maturation.
(A) Immunofluorescence image of COPG2 in maturate porcine oocyte with/without EGF (scale bar: 50 µm), (B) comparison of fluorescence intensity. Asterisk indicate significant difference (P<0.05).